Gene information
Official symbol IL1RL1
Official full name interleukin 1 receptor like 1
Gene type protein-coding gene
Chromosome2q12.1
Alias symbolST2; FIT-1; ST2L; ST2V; DER4; T1; IL33R
Gene familyI-set domain containing; Interleukin receptors; TIR domain containing
Resources
Entrez Gene 9173
HGNC HGNC:5998
Ensembl ENSG00000115602
Vega OTTHUMG00000130782
UCSC uc002tbu.1
GO terms: 29 records
GO Description Category LogP Number of genes Detail
GO:0001818 negative regulation of cytokine production GO Biological Processes -48.9957481 97 More
GO:0001819 positive regulation of cytokine production GO Biological Processes -44.1872667 64 More
GO:0002683 negative regulation of immune system process GO Biological Processes -26.6415063 77 More
GO:0002694 regulation of leukocyte activation GO Biological Processes -32.0887020 60 More
GO:0002696 positive regulation of leukocyte activation GO Biological Processes -27.9249645 47 More
GO:0002819 regulation of adaptive immune response GO Biological Processes -16.0189388 24 More
GO:0002822 regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains GO Biological Processes -14.6775052 22 More
GO:0004896 cytokine receptor activity GO Molecular Functions -9.30297759 21 More
GO:0005925 focal adhesion GO Cellular Components -8.40302345 46 More
GO:0016798 hydrolase activity, acting on glycosyl bonds GO Molecular Functions -2.52984204 7 More
GO:0019221 cytokine-mediated signaling pathway GO Biological Processes -27.5840932 43 More
GO:0019955 cytokine binding GO Molecular Functions -19.1485102 24 More
GO:0030055 cell-substrate junction GO Cellular Components -9.04790297 48 More
GO:0031347 regulation of defense response GO Biological Processes -64.5971043 148 More
GO:0031349 positive regulation of defense response GO Biological Processes -32.1301903 71 More
GO:0032103 positive regulation of response to external stimulus GO Biological Processes -58.7273809 118 More
GO:0032642 regulation of chemokine production GO Biological Processes -25.2850711 37 More
GO:0032649 regulation of interferon-gamma production GO Biological Processes -12.4733429 27 More
GO:0032689 negative regulation of interferon-gamma production GO Biological Processes -6.05054543 11 More
GO:0032722 positive regulation of chemokine production GO Biological Processes -22.4503100 21 More
GO:0043030 regulation of macrophage activation GO Biological Processes -14.6396218 15 More
GO:0043032 positive regulation of macrophage activation GO Biological Processes -14.1432953 16 More
GO:0050727 regulation of inflammatory response GO Biological Processes -68.5964592 121 More
GO:0050729 positive regulation of inflammatory response GO Biological Processes -38.1621935 57 More
GO:0050777 negative regulation of immune response GO Biological Processes -11.1440698 32 More
GO:0050865 regulation of cell activation GO Biological Processes -40.6877761 71 More
GO:0050867 positive regulation of cell activation GO Biological Processes -31.2431659 51 More
GO:0071345 cellular response to cytokine stimulus GO Biological Processes -39.647808 70 More
GO:0140375 immune receptor activity GO Molecular Functions -8.53513203 25 More
KEGG pathways: 1 record
KEGG Description Category LogP Number of genes Detail
hsa04060 Cytokine-cytokine receptor interaction KEGG Pathway -61.0014447 66 More
Related studies: 42 records
Molecular factor Omics type Application Objective MI type Reference
interleukin-1 receptor-like 1 proteomics death[prognosis (bad)] acute ST elevation myocardial infarction Shimpo M et al. Circulation. 2004
interleukin-1 receptor-like 1 proteomics cardiovascular death;heart failure[prognosis (bad)] acute myocardial infarction Sabatine MS et al. Circulation. 2008
interleukin-1 receptor-like 1 proteomics left ventricular remodeling[prognosis (bad)] acute myocardial infarction Weir RA et al. J Am Coll Cardiol. 2010
interleukin-1 receptor-like 1 proteomics medium predictor death[prognosis (bad)] acute non-ST elevation myocardial infarction Dhillon OS et al. Am Heart J. 2011
interleukin-1 receptor-like 1 proteomics poor predictor death[prognosis (bad)] acute non-ST elevation myocardial infarction Dhillon OS et al. Am Heart J. 2011
interleukin-1 receptor-like 1 proteomics major adverse cardiovascular events[prognosis (bad)] acute non-ST elevation myocardial infarction Dhillon OS et al. Am Heart J. 2011
interleukin-1 receptor-like 1 proteomics recurrent myocardial infarction[prognosis (bad)] acute non-ST elevation myocardial infarction Dhillon OS et al. Am Heart J. 2011
interleukin-1 receptor-like 1 proteomics death[prognosis (bad)] acute ST elevation myocardial infarction Dhillon OS et al. Int J Cardiol. 2013
interleukin-1 receptor-like 1 proteomics death[prognosis (bad)] acute ST elevation myocardial infarction Dhillon OS et al. Int J Cardiol. 2013
interleukin-1 receptor-like 1 proteomics excellent predictor adverse events[prognosis (bad)] acute myocardial infarction Zhang K et al. Chin Med J (Engl). 2013
interleukin-1 receptor-like 1 proteomics medium predictor acute kidney failure[prognosis (bad)] acute ST elevation myocardial infarction Tung YC et al. PLoS One. 2015
interleukin-1 receptor-like 1 proteomics myocardial infarction[diagnosis] myocardial infarction Gruzdeva OV et al. Ter Arkh. 2016
interleukin-1 receptor-like 1 proteomics medium predictor complication[prognosis (bad)] ST elevation myocardial infarction Barbarash O et al. Ann Lab Med. 2016
interleukin-1 receptor-like 1 proteomics cardiovascular death;heart failure[prognosis (bad)] acute ST elevation myocardial infarction O'Donoghue ML et al. J Am Heart Assoc. 2016
interleukin-1 receptor-like 1 proteomics death[prognosis (bad)] acute myocardial infarction Jenkins WS et al. Am J Med. 2017
interleukin-1 receptor-like 1 proteomics heart failure[prognosis (bad)] acute myocardial infarction Jenkins WS et al. Am J Med. 2017
interleukin-1 receptor-like 1 proteomics good predictor major adverse cardiovascular events[prognosis (bad)] acute myocardial infarction Wang YP et al. J Cell Mol Med. 2017
interleukin-1 receptor-like 1 proteomics good predictor acute non-ST elevation myocardial infarction[diagnosis] acute non-ST elevation myocardial infarction Schernthaner C et al. Eur J Clin Invest. 2017
interleukin-1 receptor-like 1 proteomics good predictor acute myocardial infarction[diagnosis] acute myocardial infarction Schernthaner C et al. Eur J Clin Invest. 2017
interleukin-1 receptor-like 1 proteomics excellent predictor acute ST elevation myocardial infarction[diagnosis] acute ST elevation myocardial infarction Schernthaner C et al. Eur J Clin Invest. 2017
interleukin-1 receptor-like 1 proteomics major adverse cardiac and cerebral events[prognosis (bad)] ST elevation myocardial infarction Yu J et al. PLoS One. 2017
interleukin-1 receptor-like 1 proteomics left ventricular remodeling[prognosis (bad)] acute ST elevation myocardial infarction Biere L et al. Int J Cardiol. 2018
interleukin-1 receptor-like 1 proteomics cardiovascular adverse events[prognosis (bad)] ST elevation myocardial infarction Huang WP et al. Chin Med J (Engl). 2018
interleukin-1 receptor-like 1 proteomics good predictor death[prognosis (bad)] acute non-ST elevation myocardial infarction Kokkoz C et al. Turk J Emerg Med. 2018
interleukin-1 receptor-like 1 proteomics left ventricular remodeling[prognosis (bad)] acute ST elevation myocardial infarction Minana G et al. Int J Cardiol. 2018
interleukin-1 receptor-like 1 proteomics cardiovascular adverse events[prognosis (bad)] acute ST elevation myocardial infarction Hartopo AB et al. Cardiol Res Pract. 2018
interleukin-1 receptor-like 1 proteomics acute kidney failure[prognosis (bad)] acute ST elevation myocardial infarction Kopytsya M et al. Georgian Med News. 2018
interleukin-1 receptor-like 1 proteomics medium predictor major adverse cardiovascular events[prognosis (bad)] ST elevation myocardial infarction Liu X et al. Int Heart J. 2019
interleukin-1 receptor-like 1 proteomics medium predictor death[prognosis (bad)] ST elevation myocardial infarction Liu X et al. Int Heart J. 2019
interleukin-1 receptor-like 1 proteomics poor predictor no-reflow phenomenon[prognosis (bad)] ST elevation myocardial infarction Somuncu MU et al. J Atheroscler Thromb. 2019
interleukin-1 receptor-like 1 proteomics good predictor left ventricular remodeling[prognosis (bad)] acute anterior ST elevation myocardial infarction Kercheva M et al. Clin Med Insights Cardiol. 2019
interleukin-1 receptor-like 1 proteomics good predictor left ventricular remodeling[prognosis (bad)] acute ST elevation myocardial infarction Gruzdeva O et al. Aging (Albany NY). 2019
interleukin-1 receptor-like 1 proteomics poor predictor cardiovascular death;heart failure hospitalization[prognosis (bad)] acute ST elevation myocardial infarction Tyminska A1 et al. Pol Arch Intern Med. 2019
interleukin-1 receptor-like 1 proteomics acute anterior ST elevation myocardial infarction[diagnosis] acute anterior ST elevation myocardial infarction Hojagergaard MA et al. Biomarkers. 2020
interleukin-1 receptor-like 1 proteomics good predictor cardiovascular death[prognosis (bad)] acute ST elevation myocardial infarction Zagidullin N et al. J Clin Med. 2020
interleukin-1 receptor-like 1 proteomics left ventricular remodeling[prognosis (bad)] acute ST elevation myocardial infarction Kim M et al. Cardiol J. 2020
interleukin-1 receptor-like 1 proteomics cardiovascular death[prognosis (bad)] acute myocardial infarction Somuncu MU et al. Horm Mol Biol Clin Investig. 2020
interleukin-1 receptor-like 1 proteomics left ventricular remodeling[prognosis (bad)] acute ST elevation myocardial infarction Pecherina T et al. Diagnostics (Basel). 2020
interleukin-1 receptor-like 1 proteomics acute kidney failure[prognosis (bad)] acute ST elevation myocardial infarction Vyshnevska I et al. Georgian Med News. 2020
interleukin-1 receptor-like 1 proteomics sacubitril plus valsartan[treatment (pharmacotherapy)] acute ST elevation myocardial infarction Zhang Y et al. Coron Artery Dis. 2020
interleukin-1 receptor-like 1 proteomics contrast-induced nephropathy[prognosis (bad)] acute ST elevation myocardial infarction Avci A et al. Int J Gen Med. 2020
interleukin-1 receptor-like 1 proteomics atorvastatin plus ticagrelor[treatment (pharmacotherapy)] ST elevation myocardial infarction Zhang L et al. J Int Med Res. 2020
All rights reserved: Soochow University Center for Systems Biology